Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALPG | P10696 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.44 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5155052 | 0.86 | ALDH1A1 (0.57) | ALDH1A1AOX1TDP1TRIM24HPGD | |
| SCHEMBL2391793 | 0.86 | ALDH1A1 (0.46) | TPMTALDH1A1KMT2AMEN1GAA | |
| SCHEMBL29361496 | 0.79 | ALDH1A1 (0.59) | TPMTALDH1A1GAALMNAMAPT | |
| SCHEMBL6291227 | 0.79 | SRC (0.53) | ALDH1A1AOX1TDP1TRIM24HPGD | |
| SCHEMBL3637463 | 0.79 | CA1 (0.55) | ALDH1A1AOX1TDP1TRIM24HPGD | |
| SCHEMBL1050289 | 0.79 | ALDH1A1 (0.59) | TPMTALDH1A1GAALMNAMAPT | |
| SCHEMBL524215 | 0.79 | KMT2A (0.55) | ALDH1A1KMT2AMEN1GAAMAPT | |
| SCHEMBL1159670 | 0.78 | TUBB1 (0.49) | ALDH1A1AOX1TDP1TRIM24HPGD | |
| SCHEMBL16411026 | 0.78 | KMT2A (0.41) | TPMTALDH1A1KMT2AGAAMAPT | |
| SCHEMBL2807788 | 0.78 | TPMT (0.54) | TPMTALDH1A1KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240130988-A1 | Use of stilbene compounds in the preparation of anti-tumor drugs | GUANGZHOU ANHAO PHARMACEUTICAL TECHNOLOGY CO LTD. (CN) | 2024-04-25 | — | — | US | disclosed |
| EP-4342463-A1 | STILBENE COMPOUNDS FOR USE IN THE TREATMENT OF TUMOUR AND EYE DISEASES | Guangzhou AnHao Pharmaceutical Technology Co., Ltd. (CN) | 2024-03-27 | — | — | EP | disclosed |
| CN-115444841-B | Application of stilbene compounds in preparation of antitumor drugs | 广州安好医药科技有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-115444841-A | Application of stilbene compound in preparation of antitumor drugs | 广州安好医药科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| EP-2168952-B1 | MORPHOLINE DERIVATIVES AS RENIN INHIBITORS | MITSUBISHI TANABE PHARMA CORP (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-8975252-B2 | Morpholine derivative | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2015-03-10 | — | — | US | disclosed |
| CN-101679324-B | Morpholine derivatives | MITSUBISHI TANABE PHARMA CORP | 2012-10-03 | — | — | CN | disclosed |
| US-20100240644-A1 | MORPHOLINE DERIVATIVE | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2010-09-23 | — | — | US | disclosed |
| EP-2168952-A1 | MORPHOLINE DERIVATIVE | Mitsubishi Tanabe Pharma Corporation (JP) | 2010-03-31 | — | — | EP | disclosed |
| CN-101679324-A | Morpholine derivatives | MITSUBISHI TANABE PHARMA CORP | 2010-03-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240644-A1 | MORPHOLINE DERIVATIVE | REN, AGTR1, AGTR2 | TPMT 1440/4885ALDH1A1 2202/4885KMT2A 1278/4885 |
| US-20240130988-A1 | Use of stilbene compounds in the preparation of anti-tumor drugs | CD4, CD81, NFATC1 | TPMT 1434/4885ALDH1A1 1799/4885KMT2A 4251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.